2019 Annual General Meeting

Members are invited to attend the 2019 Annual General Meeting (AGM) of Research Australia Limited on Thursday 28 November at 09.30am to be  held at the Garvan Institute of Medical Research, Level 7 Boardroom, 384 Victoria Street, Darlinghurst NSW.

As you are no doubt aware, the AGM is a statutory requirement to receive and consider the financial statements and reports of directors, and election of directors.  It is anticipated that the AGM will run for a short time and will be followed by a light morning tea.

The following business will be transacted during the AGM:

ORDINARY BUSINESS
Annual overview.

ANNUAL ACCOUNTS
To consider the annual report, financial statements and report of the Directors and Auditor for the year ended 30 June 2019.

RESULTS OF DIRECTOR APPOINTMENT/S
To note the Directors who return and the appointment of new Director/s in accordance with the Company’s Constitution.

OTHER BUSINESS
Any other business that may be brought forward at a general meeting in accordance with the Constitution.

Note: A Member who is entitled to vote at the meeting has a right to appoint a proxy and should use the proxy form available here.  One vote is entitled per member organisation.

The proxy form must be signed and dated by the Member and must be received via email no later than 5:00 pm Monday 25 November 2019.

CALL FOR DIRECTOR NOMINATIONS
Research Australia is seeking nominations for consideration for it’s Board of Directors. Eligibility and responsibilities applicable for this role can be found here.  This process opens today 6 November 2019 and will close no later than 5.00pm Monday 25 November 2019.

If you have any questions regarding the election process and/or the AGM please do not hesitate to contact Nadia Levin, CEO & Managing Director on (02) 9295 8547 or nadia.levin@researchaustralia.org.

By Order of the Board

Sent by Research Australia, 384 Victoria Street DARLINGHURST NSW 2010
UNSUBSCRIBE

 

2019 Australia Speaks! Opinion Poll Media Release

Australians say health and medical research matters!

Australians’ opinions matter when it comes to our healthcare system and the research that underpins it.

The national peak body, Research Australia, has asked Australians for their opinions on health for the past 17 years and consistently they consistently tell us that research is crucial to better health and living our best lives.

The Minister for Health, the Hon. Greg Hunt launched the 2019 consumer poll Australia Speaks! at Parliament House yesterday to an audience of Research Australia’s Members along with government representatives, sector leaders and other health organisations.

The Minister said, ‘What is clear from this poll is that Australians value their own and government investments in health and medical research for delivering good health outcomes. Health and medical research is a key priority of the Government, that’s why we are investing $20 billion in the Medical Research Future Fund.’

“Health and medical research is about people so each year, with the generous help of Roy Morgan, we ask consumers for their opinions to enable us to reflect their values, and those of our Members, to ensure policy supports our health system.” says Nadia Levin, CEO of Research Australia.

“It is clear Australians see improving hospitals and healthcare as the number one spending priority for the Australian Government, even ahead of infrastructure, education standards and employment opportunities. 

“Three quarters of Australians say they are interested in health and medical research.  However, while confident in their ability to contribute to decision making about the future direction of the sector, most Australians don’t know how, and many don’t believe they’d be heard.  Our governments and research organisations clearly have more work to do to meaningfully engage with the broader community.”

The results also confirmed that Australians are willing to embrace technology that can help them better manage their own health. They trust healthcare professionals to assist them with choosing those technologies and directing them to other credible online information sources.  Professor Mary Foley, Managing Director Telstra Health and Research Australia Director shared her views around the impact of data in supporting improved health and what the future holds with the ongoing advances in technology.

The subject of ‘The empowered patient and consumer – managing our own health’ was discussed in a panel made up of sector leaders including the CEO of the Foundation for Alcohol Research & Education Michael Thorn, the CEO of Diabetes Australia, Greg Johnson and Jeppe Theisen, Vice President and General Manager Oceania, Novo Nordisk.  Each discussed the importance of preventative medicine and what they are doing in this space to support Australians.

The poll also covered donations and government funding, and once again support for health and medical research is widespread.  And at a time when we see the government partnering with the not for profit sector to support health and medical research, people indicated they would be more likely to donate a higher amount if the government would match their donation – a sentiment also reflected in previous polls.

Australians’ opinions continue to shape Research Australia’s strategies and priorities and observations of the changing trends and current attitudes will be shared widely to help shape policy and change to enable a healthier Australia.

Research Australia and Roy Morgan research are proud to release the results of the 2019 poll and further information is available by clicking here.  

For more information please contact us on (02) 9295 8545 or admin@researchaustralia.org or follow us on Twitter on @ResAustralia

 

“Rising to the challenge of medication harm requires communication and care”

One of Research Australia’s Health Services Research Award nominees, Professor Libby Roughead, wrote an article for the not-for-profit journalism organisation Croakey.

“In 2017 the World Health Organization launched a global challenge to reduce severe, avoidable harm related to medications, by fifty percent within the next five years.

Each participating country will bring its own set of circumstances to the challenge. In Australia, the Australian Commission on Safety and Quality in Health Care released a discussion paper earlier this year, seeking submissions on how we can use our existing systems to achieve the goal, and where we need to bridge the gaps.

Professor Libby Roughead is Director of the Quality Use of Medicines and Pharmacy Research Centre at the University of South Australia.

In the post below, she outlines the challenge ahead, reminding us that, at its heart, medication harm is a problem that centres on people.” – Croakey

Please click here to view the article

 

Fighting superbugs smartly – Researcher recognised for her work in stopping sepsis.

MEDIA RELEASE                                                                              13 September 2019

Fighting superbugs smartly – Researcher recognised for her work in stopping sepsis

A doctor behind a program saving lives and cutting hospital stays across Victoria has been recognised by Australia’s peak research body for her work driving international leadership in antimicrobial stewardship.

Smarter use of antibiotics and other antimicrobial medicines – drawing upon data showing when and how they are being prescribed – has been a key focus of Professor Karin Thursky’s career, with tangible benefits to patients shown in a major study released this week.

The study has shown the effectiveness of Better Care Victoria’s ‘Think Sepsis. Act Fast’ program, which was led by Professor Thursky, demonstrating it saved 52 lives and avoided 96 ICU admissions while in use at 11 Victorian health services over four months. Today is World Sepsis Day, bringing awareness to this critical health issue.

Professor Thursky, who is director of the National Centre for Antimicrobial Stewardship at the Doherty Institute, has now been selected as a finalist in the Health Services Research category of Research Australia’s Health and Medical Awards for her leadership and work that has led to a significant improvement in healthcare.

‘Think Sepsis. Act Fast’ is a clinical pathway which improves outcomes for patients with suspected sepsis through earlier identification and management. It aims to decrease the rate of inpatient sepsis-related mortality, decrease hospital length of stay for patients with sepsis, and decrease sepsis-related ICU admissions while also targeting clinicians’ use of antibiotic therapy to ensure timely and appropriate use.

The recent collaboration between Victorian health services demonstrated a six-fold return on investment with an $11.7 million saving based on reduced length of stay and reduction in costs.

There was a significant improvement in patient outcomes, with a 50 per cent decrease in mortality and 34 per cent decrease in ICU admissions.

Furthermore, the study showed a 28.8 per cent increase in appropriateness of initial antibiotic therapy, highlighting how Australian health care practitioners still have large gains to make in improving their use of antibiotics.

“We know our national appropriateness rate in hospitals (for antibiotic use) is around 73 per cent,” said Professor Thursky, who acted as clinical lead on the collaboration. “It means 1 in 4 prescriptions is still not appropriate, but we can dive deep into the data to find the areas we need to improve in.

“We’ve become international leaders in hospital stewardship. No one else collects the type of data we’re able to collect.”

Professor Thursky leads the National Antimicrobial Prescribing Survey (NAPS) which helps healthcare services assess their prescribing practice. Her team also plays a key role in implementing the National Antimicrobial Resistance Strategy, training doctors, pharmacists, nurses and other professionals for better use of antibiotics.

The clinical pathway for ‘Think Sepsis. Act Fast’ was originally developed at Peter MacCallum Cancer Centre, where Professor Thursky leads the implementation stream of the Centre of Research Excellence – National Centre for Infections in Cancer.

Research Australia CEO Nadia Levin said Professor Thursky’s work was making a significant impact nationally and internationally on how healthcare providers prescribe antimicrobials such as antibiotics, leading the fight against resistance.

“Professor Thursky has been a key contributor to the successful Guidance Group, based at Royal Melbourne Hospital, which developed software to actively improve clinical use of restricted antimicrobials,” she said.

“Guidance works to support stewardship programs by requiring the doctors to document why they are using antibiotics or restricted antimicrobials. That data is used on a day to day level by the stewardship teams who can undertake a review, encouraging more appropriate prescribing and better results for patients.”

The Guidance System is now used at 70 hospitals across Australia.

Research Australia’s Health and Medical Research Awards recognise the invaluable contributions made to Australian health and medical research, be it through ground-breaking research and discovery, ongoing advocacy or generous philanthropic donations that make innovation possible. The event is attended by some of the country’s most notable researchers, leaders from the Australian public service, key sector influencers and some of the younger researchers making global breakthroughs.

The winners will be announced at the official Awards ceremony on Thursday 14 November at Metropolis Ballroom in Southbank, Melbourne.

Professor Thursky is available for interviews.

Media contact: Pia Akerman, 0412 346 746

 

 

Research Matters July 2019

Welcome to Research Matters. With the Federal election quickly receding in the rearview mirror, we take a look at the implications for health and medical research and in particular, what might be coming up.

To contribute to or discuss any of the items in this edition, please email Greg Mullins, Head of Policy, at greg.mullins@researchaustralia.org, or on (03) 9662 9420.

This communication features important information on:

  1. Research Funding – MRFF & NHMRC
  2. Personal Health Information 
  3. Prevention
  4. R&D

Please click here to view Research Matters July 2019